PITTSBURGH, Sept. 05, 2023 (GLOBE NEWSWIRE) — Carmell Corporation (Nasdaq: CTCX) (“Carmell”), a regenerative care company, today announced the completion of post-merger integration with Flagstaff-based Axolotl Biologix, a profitable regenerative medicine company (“Axolotl”). As part of the post-merger planning process, Carmell announced the following changes effective September 1, 2023: Rajiv…Read More
Carmell Therapeutics Corporation Carmell Corporation Announces Completion of PostMerger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics
